by Nasometry devices are medical instruments used to measure and analyze the nasal cycle and nasal patency objectively and quantitatively. Nasal cycle refers to the rhythmic alteration between the airflow through the left and right nostrils, which tends to maximize heat and moisture exchange. Nasal patency denotes the degree of nasal airflow obstruction or congestion. Nasometry devices help assess nasal dysfunction with conditions like congestion, polyps, septal deviations, and allergies. They find use in pre- and post-surgery evaluation and research on the nasal cycle. The global nasometry devices market is estimated to be valued at US$ 336.9 million in 2024 and is expected to exhibit a CAGR of 4.3% over the forecast period of 2024 to 2031.
Market Drivers
The rising geriatric population susceptible to nasal dysfunctions is a key factor driving the Global Nasometry devices Market Demand. Growing awareness about nasal assessment aids in clinical decision making and research is also propelling the demand. Increasing healthcare expenditure and availability of reimbursements for nasal surgery procedures boost the market. Moreover, technological upgrades of nasometry devices make them more affordable and user-friendly, extending their adoption.
Key Takeaways
Key players operating in the nasometry devices market are GM Instruments Ltd., Rose Medical Solutions Ltd., PENTAX Medical, Otopront GmbH, BioRESEARCH Associates, Inc., Medtronic, Homoth Medizinelektronik, Recorders & Medicare Systems Private Limited, Atmos MedizinTechnik GmbH & Co.KG, Collin Medical, Euroclinic MediCare Solutions, SWORD MEDICAL LTD., Glottal Enterprises Incorporated, and Vivos Therapeutics Inc.
The key opportunities in the market include rising prevalence of sinus & nasal diseases and growing adoption of technologically advanced instruments for measuring nasal functions objectively. Technological advancements like compact portable devices, integration of sensors & software, automatic data analysis are expanding the application areas of nasometry.
Current challenges in Nasometry Devices Market
The nasometry devices market has witnessed slow growth historically due to lack of awareness among consumers regarding availability of such devices and their benefits. Also, the market has been dominated by few regional players restricting the growth opportunities. High cost of advanced devices is another barrier restricting wider adoption especially in price sensitive developing markets. Moreover, lack of skilled professionals to operate these devices and interpret the results have further limited the market expansion.
SWOT Analysis
Strength: Non-invasive procedures, quick and easy to use, accurate and reliable measurement of nasal airflow.
Weakness: High cost of advanced devices, require regular maintenance and calibration.
Opportunity: Increasing cases of nasal obstructions worldwide, scope for new product development.
Threats: Competition from alternative therapies such as medicated nasal sprays, strong presence of local players influencing pricing.
Geographical Regions
North America region dominates the global nasometry devices market currently accounting for over 40% value share owing to significant nasometry procedures performed, higher acceptance of advanced medical technologies and presence of major players. Europe is the second leading region due to rising prevalence of respiratory disorders and availability of favorable reimbursement policies for such procedures.
Fastest growing region
Asia Pacific region is poised to witness highest growth during the forecast period in the nasometry devices market supported by expanding medical infrastructure, growing medical tourism industry and increasing health insurance coverage in emerging countries like India and China leading to wider adoption. Rapidly aging population susceptible to nasal disorders further aids the regional market growth.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
